Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltefosine and Pentoxifylline for Mucosal and Cutaneous Leishmaniasis
NCT02530697Phase 2Active, not recruiting
- Sponsor
- University of Brasília
- Start
- Aug 2015
- Primary completion
- Aug 2025
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of miltefosine in mucocutaneous leishmaniasis (MCL), cutaneous leishmaniasis (CL), sponsored by University of Brasília. Started Aug 2015; status: active, not recruiting.
02
Drugs
miltefosine
03
Conditions
mucocutaneous leishmaniasis (MCL)cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT02530697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02530697.